Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC

Rakesh K. Singh, Ph.D., M.Phil.


Showing all 47 journal articles & 0 books available

Journal Articles

James NE, Emerson JB, Borgstadt AD, Beffa L, Oliver MT, Hovanesian V, Urh A, Singh RK, Rowswell-Turner R, DiSilvestro PA, Ou J, Moore RG, Ribeiro JR. "The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes." Scientific reports.. 2020 May 22; 10(1):8558. Epub 2020 May 22.

Kim KK, Singh RK, Khazan N, Kodza A, Singh NA, Jones A, Sivagnanalingam U, Towner M, Itamochi H, Turner R, Moore RG. "Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines." Scientific reports.. 2020 Feb 24; 10(1):3241. Epub 2020 Feb 24.

Kim KK, Turner R, Khazan N, Kodza A, Jones A, Singh RK, Moore RG. "Role of trypsin and protease-activated receptor-2 in ovarian cancer." PloS one.. 2020 15(5):e0232253. Epub 2020 May 04.

Rowswell-Turner RB, Rutishauser JA, Kim KK, Khazan N, Sivagnanalingam U, Jones AM, Singh RK, Moore RG. "Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer." Translational oncology.. 2019 Jul 0; 12(7):917-924. Epub 2019 May 10.

James NE, Oliver MT, Ribeiro JR, Cantillo E, Rowswell-Turner RB, Kim KK, Chichester CO, DiSilvestro PA, Moore RG, Singh RK, Yano N, Zhao TC. "Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6." Frontiers in pharmacology.. 2019 10:216. Epub 2019 Mar 19.

James NE, Cantillo E, Oliver MT, Rowswell-Turner RB, Ribeiro JR, Kim KK, Chichester CO, DiSilvestro PA, Moore RG, Singh RK, Yano N, Zhao TC. "HE4 suppresses the expression of osteopontin in mononuclear cells and compromises their cytotoxicity against ovarian cancer cells." Clinical and experimental immunology.. 2018 Sep 0; 193(3):327-340.

Ribeiro JR, Schorl C, Yano N, Romano N, Kim KK, Singh RK, Moore RG. "HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells." Journal of ovarian research.. 2016 May 17; 9(1):28. Epub 2016 May 17.

Kim KK, Han A, Yano N, Ribeiro JR, Lokich E, Singh RK, Moore RG. "Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers." Scientific reports.. 2015 Nov 16; 5:15911. Epub 2015 Nov 16.

Kim KK, Abelman S, Yano N, Ribeiro JR, Singh RK, Tipping M, Moore RG. "Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1? in cancer cells." Scientific reports.. 2015 Oct 15; 5:14296. Epub 2015 Oct 15.

Wang Y, Han A, Chen E, Singh RK, Chichester CO, Moore RG, Singh AP, Vorsa N. "The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells." International journal of oncology.. 2015 May 0; 46(5):1924-34. Epub 2015 Mar 17.

Sidhu PS, Teske K, Feleke B, Yuan NY, Guthrie ML, Fernstrum GB, Vyas ND, Han L, Preston J, Bogart JW, Silvaggi NR, Cook JM, Singh RK, Bikle DD, Arnold LA. "Anticancer activity of VDR-coregulator inhibitor PS121912." Cancer chemotherapy and pharmacology.. 2014 Oct 0; 74(4):787-98. Epub 2014 Aug 09.

Lokich E, Singh RK, Han A, Romano N, Yano N, Kim K, Moore RG. "HE4 expression is associated with hormonal elements and mediated by importin-dependent nuclear translocation." Scientific reports.. 2014 Jun 30; 4:5500. Epub 2014 Jun 30.

Sidhu PS, Nassif N, McCallum MM, Teske K, Feleke B, Yuan NY, Nandhikonda P, Cook JM, Singh RK, Bikle DD, Arnold LA. "Development of novel Vitamin D Receptor-Coactivator Inhibitors." ACS medicinal chemistry letters.. 2014 Feb 13; 5(2):199-204.

Moore RG, Hill EK, Horan T, Yano N, Kim K, MacLaughlan S, Lambert-Messerlian G, Tseng YD, Padbury JF, Miller MC, Lange TS, Singh RK. "HE4 (WFDC2) gene overexpression promotes ovarian tumor growth." Scientific reports.. 2014 Jan 6; 4:3574. Epub 2014 Jan 06.

Teske K, Nandhikonda P, Bogart JW, Feleke B, Sidhu P, Yuan N, Preston J, Goy R, Han L, Silvaggi NR, Singh RK, Bikle DD, Cook JM, Arnold LA. "IDENTIFICATION OF VDR ANTAGONISTS AMONG NUCLEAR RECEPTOR LIGANDS USING VIRTUAL SCREENING." Nuclear receptor research.. 2014 1

Kawar N, Maclaughlan S, Horan TC, Uzun A, Lange TS, Kim KK, Hopson R, Singh AP, Sidhu PS, Glass KA, Shaw S, Padbury JF, Vorsa N, Arnold LA, Moore RG, Brard L, Singh RK. "PT19c, Another Nonhypercalcemic Vitamin D2 Derivative, Demonstrates Antitumor Efficacy in Epithelial Ovarian and Endometrial Cancer Models." Genes & cancer.. 2013 Nov 0; 4(11-12):524-34.

Kristjansdottir K, Kim K, Choi JS, Horan TC, Brard L, Moore RG, Singh RK. "7 Methyl indole ethyl isothiocyanate causes ROS mediated apoptosis and cell cycle arrest in endometrial cancer cells." Gynecologic oncology.. 2012 Aug 0; 126(2):252-8. Epub 2012 May 02.

Kim KK, Lange TS, Singh RK, Brard L, Moore RG. "Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C." BMC cancer.. 2012 Apr 13; 12:147. Epub 2012 Apr 13.

Kim KK, Singh AP, Singh RK, Demartino A, Brard L, Vorsa N, Lange TS, Moore RG. "Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cells." International journal of oncology.. 2012 Jan 0; 40(1):227-35. Epub 2011 Sep 12.

Lange TS, Horan TC, Kim KK, Singh AP, Vorsa N, Brard L, Moore RG, Singh RK. "Cytotoxic properties of Adamantyl isothiocyanate and potential in vivo metabolite adamantyl-N-acetylcystein in gynecological cancer cells." Chemical biology & drug design.. 2012 Jan 0; 79(1):92-103. Epub 2011 Nov 04.

Singh AP, Lange TS, Kim KK, Brard L, Horan T, Moore RG, Vorsa N, Singh RK. "Purified cranberry proanthocyanidines (PAC-1A) cause pro-apoptotic signaling, ROS generation, cyclophosphamide retention and cytotoxicity in high-risk neuroblastoma cells." International journal of oncology.. 2012 Jan 0; 40(1):99-108. Epub 2011 Oct 06.

Moore RG, Lange TS, Robinson K, Kim KK, Uzun A, Horan TC, Kawar N, Yano N, Chu SR, Mao Q, Brard L, DePaepe ME, Padbury JF, Arnold LA, Brodsky A, Shen TL, Singh RK. "Efficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft model." PloS one.. 2012 7(4):e34443. Epub 2012 Apr 03.

Brard L, Lange TS, Robison K, Kim KK, Ara T, McCallum MM, Arnold LA, Moore RG, Singh RK. "Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell lines." Gynecologic oncology.. 2011 Nov 0; 123(2):370-8. Epub 2011 Jul 30.

Stuckey A, Fischer A, Miller DH, Hillenmeyer S, Kim KK, Ritz A, Singh RK, Raphael BJ, Brard L, Brodsky AS. "Integrated genomics of ovarian xenograft tumor progression and chemotherapy response." BMC cancer.. 2011 Jul 22; 11:308. Epub 2011 Jul 22.

Kim KK, Kawar NM, Singh RK, Lange TS, Brard L, Moore RG. "Tetrathiomolybdate induces doxorubicin sensitivity in resistant tumor cell lines." Gynecologic oncology.. 2011 Jul 0; 122(1):183-9. Epub 2011 May 06.

Singh RK, Dorf L, DeMartino A, Illenye S, Koto K, Currier EA, Ashikaga T, Kim KK, Brard L, Sholler GL. "Oral RKS262 reduces tumor burden in a neuroblastoma xenograft animal model and mediates cytotoxicity through SAPK/JNK and ROS activation in vitro." Cancer biology & therapy.. 2011 Jun 15; 11(12):1036-45. Epub 2011 Jun 15.

Koto KS, Lescault P, Brard L, Kim K, Singh RK, Bond J, Illenye S, Slavik MA, Ashikaga T, Saulnier Sholler GL. "Antitumor activity of nifurtimox is enhanced with tetrathiomolybdate in medulloblastoma." International journal of oncology.. 2011 May 0; 38(5):1329-41. Epub 2011 Mar 10.

Kim KK, Singh RK, Strongin RM, Moore RG, Brard L, Lange TS. "Organometallic iron(III)-salophene exerts cytotoxic properties in neuroblastoma cells via MAPK activation and ROS generation." PloS one.. 2011 Apr 29; 6(4):e19049. Epub 2011 Apr 29.

Singh RK, Lange TS, Kim KK, Brard L. "A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells." Investigational new drugs.. 2011 Feb 0; 29(1):63-72. Epub 2009 Oct 29.

Lange TS, Stuckey AR, Robison K, Kim KK, Singh RK, Raker CA, Brard L. "Effect of a vitamin D(3) derivative (B3CD) with postulated anti-cancer activity in an ovarian cancer animal model." Investigational new drugs.. 2010 Oct 0; 28(5):543-53. Epub 2009 Jul 07.

Lange TS, Zou Y, Singh RK, Kim KK, Kristjansdottir K, Sholler GL, Brard L. "Chemotherapeutic effect of calcidiol derivative B3CD in a neuroblastoma xenograft model." Chemical biology & drug design.. 2010 Aug 0; 76(2):164-73. Epub 2010 May 11.

Kim KK, Lange TS, Singh RK, Brard L. "Lipophilic aroylhydrazone chelator HNTMB and its multiple effects on ovarian cancer cells." BMC cancer.. 2010 Feb 25; 10:72. Epub 2010 Feb 25.

Lange TS, McCourt C, Singh RK, Kim KK, Singh AP, Luisi BS, Alptürk O, Strongin RM, Brard L. "Apoptotic and chemotherapeutic properties of iron (III)-salophene in an ovarian cancer animal model." Drug design, development and therapy.. 2009 Sep 21; 3:17-26. Epub 2009 Sep 21.

Singh AP, Singh RK, Kim KK, Satyan KS, Nussbaum R, Torres M, Brard L, Vorsa N. "Cranberry proanthocyanidins are cytotoxic to human cancer cells and sensitize platinum-resistant ovarian cancer cells to paraplatin." Phytotherapy research : PTR.. 2009 Aug 0; 23(8):1066-74.

Brard L, Singh RK, Kim KK, Lange TS, Sholler GL. "Induction of cytotoxicity, apoptosis and cell cycle arrest by 1-t-butyl carbamoyl, 7-methyl-indole-3-ethyl isothiocyanate (NB7M) in nervous system cancer cells." Drug design, development and therapy.. 2009 Feb 6; 2:61-9. Epub 2009 Feb 06.

Singh RK, Lange TS, Kim KK, Singh AP, Vorsa N, Brard L. "Isothiocyanate NB7M causes selective cytotoxicity, pro-apoptotic signalling and cell-cycle regression in ovarian cancer cells." British journal of cancer.. 2008 Dec 2; 99(11):1823-31. Epub 2008 Nov 11.

Lange TS, Kim KK, Singh RK, Strongin RM, McCourt CK, Brard L. "Iron(III)-salophene: an organometallic compound with selective cytotoxic and anti-proliferative properties in platinum-resistant ovarian cancer cells." PloS one.. 2008 May 28; 3(5):e2303. Epub 2008 May 28.

Singh RK, Lange TS, Kim KK, Shaw SK, Brard L. "A novel indole ethyl isothiocyanate (7Me-IEITC) with anti-proliferative and pro-apoptotic effects on platinum-resistant human ovarian cancer cells." Gynecologic oncology.. 2008 May 0; 109(2):240-9. Epub 2008 Mar 07.

Koto K, Brard L, Bosenberg M, Singh RK, Kim KK. Scholler GS. "RKS-2-62: A novel therapy for medulloblastoma with activity in vitro and in vivo." Neurooncology. 2008; 10: 513-514.

Singh RK, Lange TS, Kim KK, Singh AP, Hopson R, Vorsa N, Brard L. "Synthesis of Bicyclic Aryl Thiazolines with selective anti-proliferative effects on human cancer cell lines." Lett Org Chem. 2008; 5: 103-109.

Singh RK, Lange TS, Kim K, Zou Y, Lieb C, Sholler GL, Brard L. "Effect of indole ethyl isothiocyanates on proliferation, apoptosis, and MAPK signaling in neuroblastoma cell lines." Bioorganic & medicinal chemistry letters.. 2007 Nov 1; 17(21):5846-52. Epub 2007 Aug 19.

Lange TS, Singh RK, Kim KK, Zou Y, Kalkunte SS, Sholler GL, Swamy N, Brard L. "Anti-proliferative and pro-apoptotic properties of 3-bromoacetoxy calcidiol in high-risk neuroblastoma." Chemical biology & drug design.. 2007 Oct 0; 70(4):302-10.

Singh RK, Jain S, Sinha N, Mehta A, Naqvi F, Agarwal AK and Anand N. "A simple and efficient synthesis of 8-methyl-3, 8-diazabicyclo[3.2.1]octane (azatropane) and 3-substituted azatropanes therefrom using pyroglutamic acid." Tet Lett. 2007; 48: 545-548.

Satyan KS, Swamy N, Dizon DS, Singh R, Granai CO, Brard L. "Phenethyl isothiocyanate (PEITC) inhibits growth of ovarian cancer cells by inducing apoptosis: role of caspase and MAPK activation." Gynecologic oncology.. 2006 Oct 0; 103(1):261-70. Epub 2006 Apr 19.

Singh RK, Sinha N, Jain S, Naqvi F, Mehta A. "A general and efficient sythesis of 3,6-diazabicyclo[3.2.1]octanes." Tetrahedron. 2006; 62: 4011-4017.

Singh RK, Sinha N, Jain S, Naqvi F, Salman M. and Anand N. "Synthesis of optically active heterocyclic alpha-amino acids from activated lactams." Part-1. Synthesis. 2005; 16: 2765-2771.

Singh RK, Sinha N, Jain S, Naqvi F, Anand N. "Synthesis of optically active beta-heterocyclic beta-amino acids from activated lactam." Part-2. Tetrahedron. 2005; 61(37): 8868-8874.